Fig. 4From: Toxicity and antidotal treatment by synthesized and optimized ferric(III) hexacyanoferrate(II) for thalliumExcretion of Tl(I) (µg/g) through faeces. Significance is shown as ***p < 0.001, **p < 0.01, *p < 0.05 compared to positive control (Tl(I)) group, PB-1, PB-2 and marketed formulation Radiogardase®-Cs groupBack to article page